AKAnam Najib Khan

Anam Najib Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anam Najib Khan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Anirban Kundu

    National Institute of Pharmaceutical Education and Research, Kolkata, India

    1 shared publication
  • Arijit Ghosh

    Netaji Subhash Chandra Bose Cancer Research Institute, India

    1 shared publication
  • Bireswar Bhattacharya

    National Institute of Pharmaceutical Education and Research, Kolkata, India

    1 shared publication
  • Dipanjan Roy

    Department of Natural Products, National Institute of Pharmaceutical Education and Research, 168, Maniktala Main Road, Kolkata, 700054, West Bengal, India

    1 shared publication
  • Mansi Arya

    National Institute of Pharmaceutical Education and Research, Kolkata, India

    1 shared publication
  • Rahul Gupta

    Infectious Diseases & Immunology Division, Lab-254, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, Kolkata, India

    1 shared publication

Latest Publications

  • Marine Natural Products

    by Kazi Tawsif Ahmed, Rudra Chakravarti, Mansi Arya, Dipanjan Roy, Anam Najib Khan, Anirban Kundu, Rahul Gupta, Arijit Ghosh, Bireswar Bhattacharya

    The pharmaceutical industry has increasingly turned to natural product-based drug development as synthetic drug discovery declines. Marine ecosystems have become a key source of novel therapeutic agents, known as marine natural products (NPs), celebrated for their unique chemical structures and diverse biological activities. This chapter comprehensively explores marine NPs as a rich source of pharmacologically active compounds. We discuss the shift towards natural product-based drugs, the growing focus on marine ecosystems, and the diverse pharmacological actions of marine NPs. We also classify these natural products based on their sources. Furthermore, the chapter highlights marine NPs that are in various phases of clinical trials, those approved, and those already marketed as drugs. We emphasize the translational potential of marine NPs, showcasing their journey from promising leads to clinically relevant drugs, underscoring their importance as a reservoir of bioactive compounds.